Riskpilot← Back to searchSign inGet full accessBAYER NORWAY AS
ASActiveOrg 998720516Drammensveien 288, 0283 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 20129 employees
Revenue 2024
NOK 1,8M
-5% vs 2023
EBITDA margin
-16.2%
-184% vs 2023
Equity ratio
61.3%
Financial strength
Net profit 2024
NOK 33,5M
+3% vs 2023
| Revenue | NOK 1,8M | -5% |
| EBITDA | NOK -285K | -184% |
| Net profit | NOK 33,5M | +3% |
| Total assets | NOK 1,1B | +0% |
| Equity | NOK 654,3M | +37% |
| Employees | 9 | — |
Legal name
BAYER NORWAY AS
Org number
998720516
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
16. august 2012
Share capital
NOK 3 151 200
Employees
9 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Eier av juridiske enheter som opererer innenfor virksomhetsområdet biovitenskap, samt å eie andre aktiva i tilknytning til dette.
Address
Drammensveien 288, 0283 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 943 | 1 667 | 1 942 | 1 853 | 1 763 |
| Staff expenses | −1 270 | −1 692 | −1 629 | −1 332 | −1 338 |
| EBITDA | 314 | −654 | −371 | −100 | −285 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 314 | −654 | −371 | −100 | −285 |
| Net financials | −3 197 | −11 195 | −1 041 051 | 39 809 | 11 576 |
| Profit before tax | −2 883 | −11 849 | −1 041 423 | 39 709 | 11 291 |
| Tax | −28 531 | 8 972 | −6 770 | 7 046 | −22 230 |
| Net profit | 25 649 | −20 821 | −1 034 652 | 32 663 | 33 521 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 560 947 | 2 050 736 | 1 073 109 | 1 071 066 | 1 068 043 |
| Equity | 1 066 551 | 1 045 730 | 61 070 | 478 733 | 654 254 |
| Long-term debt | 1 474 000 | 995 000 | 997 500 | 585 000 | 406 000 |
| Short-term debt | 20 396 | 10 007 | 14 539 | 7 334 | 7 789 |
| Total debt | 1 494 396 | 1 005 007 | 1 012 039 | 592 334 | 413 789 |
EBITDA margin
-16.2%
This company
15.8%
Market median
-203% vs market
20202024
Equity ratio
61.3%
This company
38.2%
Market median
+60% vs market
20202024
Return on equity
5.1%
This company
18.4%
Market median
-72% vs market
20202024
Net profit margin
1901.4%
This company
8.1%
Market median
+23374% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.63×
This company
0.62×
Market median
+2% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
EH Chief Executive Officer | Chief Executive Officer | 2025 |
CT Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
MH Chief Executive Officer | Chief Executive Officer | 2017 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2022 | |
| Former (2) | ||
| Board of Directors | 2022 – 2023 | |
| Chairman | 2022 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Bayer Nordic Se | Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BAYER NORWAY AS 
BAYER ASBoard members of BAYER NORWAY AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Helstad | Chief Executive Officer | 0 companies |
| Christiane Temminghoff | Chief Executive Officer | 0 companies |
| Miriam Holstein | Chief Executive Officer | 0 companies |
| Johanna Kristiina Kouru | Board of Directors | 0 companies |
| Thorsten Gerdau | Chairman | 0 companies |
| Ann-Christin Siltvedt | Board of Directors | 0 companies |